MARKET

MYO

MYO

Myomo
AMEX

Real-time Quotes | Nasdaq Last Sale

11.54
+0.21
+1.85%
After Hours: 11.80 +0.26 +2.25% 19:23 06/14 EDT
OPEN
11.90
PREV CLOSE
11.33
HIGH
11.92
LOW
11.30
VOLUME
79.70K
TURNOVER
--
52 WEEK HIGH
18.88
52 WEEK LOW
3.460
MARKET CAP
64.67M
P/E (TTM)
-4.1753
1D
5D
1M
3M
1Y
5Y
BRIEF-Myomo Shareholders Elect Dr. Milton Morris As Director
reuters.com · 8h ago
Myomo, Inc. (MYO) Moves 5.5% Higher: Will This Strength Last?
Myomo, Inc. (MYO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks · 3d ago
Trxade, ProPhase Labs leads healthcare gainers; Aethlon Medical, Ocugen among major losers
Gainers: Trxade (MEDS) +100%, Reneo Pharmaceuticals (RPHM) +13%, ProPhase Labs (PRPH) +18%, Verona Pharma (VRNA) +13%, Myomo (MYO) +8%.Losers: Aethlon Medical (AEMD) -28%, Ocugen (OCGN) -23%, Ra Medical Systems (RMED) -16%, SCWorx (WORX) -12%, Genetic Tech...
Seekingalpha · 4d ago
Benzinga's Top Ratings Upgrades, Downgrades For June 10, 2021
 
Benzinga · 4d ago
--Alliance Global Starts Myomo at Buy with $36.50 Price Target
MT Newswires · 4d ago
BRIEF-Myomo Provides Update On CMS Discussions
reuters.com · 6d ago
Myomo Gives Update On Application For Healthcare Common Procedure Coding System Level 2 Code Change: Finalization Of Proposed Rules Has Been Delayed, Co. Withdrew Its Code Change Application
Myomo, Inc. (NYSE:MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,
Benzinga · 6d ago
Myomo Provides Update on CMS Discussions
Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today provided an update regarding its applicatio...
Business Wire · 6d ago
More
Forecast
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MYO. Analyze the recent business situations of Myomo through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MYO stock price target is 21.90 with a high estimate of 36.50 and a low estimate of 15.00.
EPS
Institutional Holdings
Institutions: 16
Institutional Holdings: 1.72M
% Owned: 30.78%
Shares Outstanding: 5.60M
TypeInstitutionsShares
Increased
5
181.43K
New
2
182.53K
Decreased
3
53.28K
Sold Out
7
253.27K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.36%
Healthcare Equipment & Supplies
+0.39%
Key Executives
Chairman/President/Founder/Chief Operating Officer/Director
Steve Kelly
Chief Executive Officer/Director
Paul Gudonis
Chief Financial Officer/Chief Accounting Officer
David Henry
General Manager
Jonathan Naft
Other
Fredrick Nahm
No Data
About MYO
Myomo, Inc. is a United States-based medical device company specializing in myoelectric orthotics for people with neurological disorders. The Company’s products help to restore function in individuals with neuromuscular conditions, such as brachial plexus injury, spinal cord injury, multiple sclerosis and stroke. Its MyoPro myoelectric limb orthosis is a powered brace that supports a weakened and deformed arm for functional use. The MyoPro is an elbow/wrist/Hand orthosis, which supports the arm and helps to bend and straighten the arm at the elbow. The brace provides assistive function for joint motion that enables a user to self-initiate and control movements of a partially paralyzed arm using their own muscle signals. When the user tries to bend their arm, sensors in the brace detect the weak muscle signal, which activates the motor to amplify their weak muscle signal to help bend and move their arm. The brace uses non-invasive skin sensors.

Webull offers kinds of Myomo Inc stock information, including AMEX:MYO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MYO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MYO stock methods without spending real money on the virtual paper trading platform.